Curated Stack
Metabolic Stack
tirzepatide
Published May 4, 2026
Protocol rationale
tirzepatide
Tirzepatide
Tirzepatide (dual GIP/GLP-1 agonist) is the most potent weight-loss peptide in Phase 3 clinical data, showing 20–22% mean body weight reduction at 72 weeks in the SURMOUNT trials. Research protocols typically start at 2.5 mg/wk and titrate upward every 4 weeks. Semaglutide (5–10 mg/wk GLP-1 agonist) is the alternative if Tirzepatide is unavailable — do not combine both.
2.5 mg/wk · 12 weeks
Interactive cost planner
Doses pre-filled from the editorial protocol. Adjust quantities and durations — costs and vendor recommendations update live.
1 — Select peptides (2–5)
Tirzepatide
metabolic
total mg
30.0
+201 more — refine your search
Share this stack with pre-filled doses
3 — Purchase plan
Cheapest option per peptide at your specified quantities. Affiliate links apply.
tirzepatide
3× 10mg vials from RetaOneLabs
$2.400/mg
$72.00
Buy →Add at least one more peptide to see cost comparison and conflict analysis.
Research purposes only. Pepticker is an editorial price comparator, not a clinical adviser. Prices are approximate and subject to change. Verify independently before any use. All vendors sell peptides for research only and not for human consumption.